This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Waismann Method® Medical Director Calls For Universal Standard Of Care For Rapid Detox Safety

BEVERLY HILLS, Calif., Oct. 3, 2013 /PRNewswire/ -- In response to recent news, including a Centers for Disease Control and Prevention (CDC) report noting severe adverse effects associated with rapid detox programs in New York, Waismann Method ® Medical Director Dr. Michael Lowenstein is calling for the creation of universal standards of care for all rapid detoxification treatments to minimize potential risks to patients.


"Unfortunately, rapid detox has become a catch-all term that encompasses a range of unregulated treatments for opiate dependency, leaving patients uneducated about important safety precautions that are vital to their health," said Dr. Lowenstein.  "It's frightening how many practitioners are not following proper safety protocol and performing rapid detox procedures under sedation or anesthesia as outpatient, leading to increased emergency hospital admissions and deaths. Rapid detox must be performed in an ICU setting, and under the strict supervision of trained medical doctors with appropriate post-treatment monitoring. When done correctly, rapid detox is safe and effective. The key is educating patients on what to look for, and restricting practitioners from cutting corners."

According to Dr. Lowenstein, the key factors that impact the safety of rapid detox procedures include:
  • Medical Screening – All rapid detox patients should undergo a detailed evaluation, including analysis of medical history and a physical examination, laboratory testing, EKG, chest x-ray, and urine toxicology screening. Additional cardiac testing may be required.  Admission to the hospital at least one day before a rapid detox procedure affords necessary time to conduct proper medical screening, hydration and pre-medication.
  • ICU Setting – Rapid opiate detoxification under sedation can significantly affect the heart, lungs, nervous system, and fluid balance in the body. For these reasons, treatment must take place in an intensive care unit, and patients should be monitored in a hospital or inpatient setting for approximately a day following the procedure so they can be appropriately treated for changes that may arise as a result of the procedure.   
  • Anesthesia –General anesthesia is unnecessary for rapid detox, and procedures that place people under for four to eight hours or more can pose great risks to patients. Waismann Method® achieves rapid detoxification using moderate sedation, avoiding general anesthesia and its associated risks.
  • Dosage – The procedures under scrutiny in New York used very large doses of Naloxone and Naltrexone to reverse opiate dependence.  Waismann Method® utilizes significantly lower doses to safely and effectively rid the body of opiates.
  • Post-Procedure Care – Patients who are sent home or to hotel rooms to recover are at much higher risk for serious injury, dehydration, pulmonary/cardiac events and even death, because they don't have qualified medical professionals to evaluate and treat potential medical emergencies.

Waismann Method®, which pioneered the procedure in 1999, has established a rigorous safety protocol for the treatment of opiate detoxification under sedation.  The protocol does not resemble other rapid detox programs performed in New York or other parts of the country that utilize general anesthesia and/or perform the procedure on an outpatient basis through clinics or surgery centers.

"Over the course of 15 years we've performed more than 3,000 rapid detox procedures with the Waismann Method®, and we've refined the process to maximize the safety and efficacy," said Dr. Lowenstein.  "It's alarming that patients are being placed in harm's way because other treatment programs are cutting corners to reduce the cost of the procedure at the expense of patient safety. Patients need to be armed with accurate information to ensure they are getting the highest level of medical attention.  It's time that experts and leaders in the medical community create a specific standard of care for rapid detox, removing the risks associated with unregulated facilities."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs